Evidence map›Paper›PMID 28649577›Full record

ArticleMolecular therapy. Methods & clinical development2017

In Vivo Murine-Matured Human CD3

Kevin G Haworth, Christina Ironside, Zachary K Norgaard, Willimark M Obenza, Jennifer E Adair, Hans-Peter Kiem

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Long-Term Persistence of Anti-HIV Broadly Neutralizing Antibody-Secreting Hematopoietic Cells in Humanized Mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kevin G HaworthClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
Christina IronsideClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
Zachary K NorgaardClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
Willimark M ObenzaClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
Jennifer E AdairClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
Hans-Peter KiemClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
Fred Hutch Cancer Center · USUniversity of Washington · US

Funding

Evaluation of Pluripotent Stem Cell-Derived Blood Cells in Nonhuman Primate ModelR01HL115128 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KIEM, HANS-PETER, RAFII, SHAHIN · 2013 to 2016
$3.3M
Cell-Based Secretion of Antiviral Molecules as a Treatment for HIV-AIDSR21AI110154 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KIEM, HANS-PETER · 2014 to 2015
$482k
NHLBI NIH HHS R01 HL115128NIAID NIH HHS R21 AI110154
6 · The paper itself

Abstract

Adoptive cellular immunotherapy is a promising and powerful method for the treatment of a broad range of malignant and infectious diseases. Although the concept of cellular immunotherapy was originally proposed in the 1990s, it has not seen successful clinical application until recent years. Despite significant progress in creating engineered receptors against both malignant and viral epitopes, no efficient preclinical animal models exist for rapidly testing and directly comparing these engineered receptors. The use of matured human T cells in mice usually leads to graft-versus-host disease (GvHD), which severely limits the effectiveness of such studies. Alternatively, adult apheresis CD34

Indexed as

ACIadoptive cellular immunotherapyCARchimeric antigen receptorHIVImmunotherapyMATCH micemouse modelNSGT cell therapy

Identifiers

PMID28649577
PMCPMC5470556
OpenAlexW2614520372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.